Immunoglobulin A Targets a Unique Subset of the Microbiota in Inflammatory Bowel Disease.

[1]  R. Xavier,et al.  Clinical and biological predictors of response to standardised paediatric colitis therapy (PROTECT): a multicentre inception cohort study , 2019, The Lancet.

[2]  W. Sandborn,et al.  Development of Clinical Prediction Models for Surgery and Complications in Crohn’s Disease , 2018, Journal of Crohn's & colitis.

[3]  Luigi Atzori,et al.  Cross sectional evaluation of the gut-microbiome metabolome axis in an Italian cohort of IBD patients , 2017, Scientific Reports.

[4]  G. Kaplan,et al.  Systematic review with meta‐analysis: comparative efficacy of biologics for induction and maintenance of mucosal healing in Crohn's disease and ulcerative colitis controlled trials , 2017, Alimentary pharmacology & therapeutics.

[5]  Judy H. Cho,et al.  Prediction of complicated disease course for children newly diagnosed with Crohn's disease: a multicentre inception cohort study , 2017, The Lancet.

[6]  N. Ajami,et al.  IgA-coated E. coli enriched in Crohn’s disease spondyloarthritis promote TH17-dependent inflammation , 2017, Science Translational Medicine.

[7]  P. Paci,et al.  Gut microbiota profiling of pediatric nonalcoholic fatty liver disease and obese patients unveiled by an integrated meta‐omics‐based approach , 2017, Hepatology.

[8]  David C. Wilson,et al.  Genome-wide association study implicates immune activation of multiple integrin genes in inflammatory bowel disease , 2016, Nature Genetics.

[9]  Yangqing Peng,et al.  Development of the gut microbiota and mucosal IgA responses in twins and gnotobiotic mice , 2016, Nature.

[10]  Amnon Amir,et al.  Partial restoration of the microbiota of cesarean-born infants via vaginal microbial transfer , 2016, Nature Medicine.

[11]  Eric Z. Chen,et al.  Inflammation, Antibiotics, and Diet as Environmental Stressors of the Gut Microbiome in Pediatric Crohn's Disease. , 2015, Cell host & microbe.

[12]  Judy H. Cho,et al.  Bridging the gap between host immune response and intestinal dysbiosis in inflammatory bowel disease: does immunoglobulin A mark the spot? , 2015, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[13]  Rob Knight,et al.  The microbiome of uncontacted Amerindians , 2015, Science Advances.

[14]  Tanya Yatsunenko,et al.  Functional characterization of IgA-targeted bacterial taxa from undernourished Malawian children that produce diet-dependent enteropathy , 2015, Science Translational Medicine.

[15]  Ryan M. O’Connell,et al.  MyD88 signaling in T cells directs IgA-mediated control of the microbiota to promote health. , 2015, Cell host & microbe.

[16]  Dan Knights,et al.  Complex host genetics influence the microbiome in inflammatory bowel disease , 2014, Genome Medicine.

[17]  Judy H. Cho,et al.  Immunoglobulin A Coating Identifies Colitogenic Bacteria in Inflammatory Bowel Disease , 2014, Cell.

[18]  M. Hattori,et al.  Foxp3(+) T cells regulate immunoglobulin a selection and facilitate diversification of bacterial species responsible for immune homeostasis. , 2014, Immunity.

[19]  A. Kostic,et al.  The microbiome in inflammatory bowel disease: current status and the future ahead. , 2014, Gastroenterology.

[20]  Se Jin Song,et al.  The treatment-naive microbiome in new-onset Crohn's disease. , 2014, Cell host & microbe.

[21]  L. T. Angenent,et al.  Innate and adaptive immunity interact to quench microbiome flagellar motility in the gut. , 2013, Cell host & microbe.

[22]  B. Stockinger,et al.  TH17 cell plasticity in Peyer’s patches is responsible for induction of T cell-dependent IgA responses , 2013, Nature Immunology.

[23]  S. Ng,et al.  Geographical variability and environmental risk factors in inflammatory bowel disease , 2013, Gut.

[24]  Francisco Guarner,et al.  The gut microbiota in IBD , 2012, Nature Reviews Gastroenterology &Hepatology.

[25]  Timothy L. Tickle,et al.  Dysfunction of the intestinal microbiome in inflammatory bowel disease and treatment , 2012, Genome Biology.

[26]  William A. Walters,et al.  Ultra-high-throughput microbial community analysis on the Illumina HiSeq and MiSeq platforms , 2012, The ISME Journal.

[27]  Eric P. Nawrocki,et al.  An improved Greengenes taxonomy with explicit ranks for ecological and evolutionary analyses of bacteria and archaea , 2011, The ISME Journal.

[28]  C. Huttenhower,et al.  Metagenomic biomarker discovery and explanation , 2011, Genome Biology.

[29]  R. Xavier,et al.  Genetics and pathogenesis of inflammatory bowel disease , 2011, Nature.

[30]  William A. Walters,et al.  QIIME allows analysis of high-throughput community sequencing data , 2010, Nature Methods.

[31]  C. Elson,et al.  A dominant, coordinated T regulatory cell-IgA response to the intestinal microbiota , 2009, Proceedings of the National Academy of Sciences.

[32]  Samir A. Shah,et al.  OSCCAR: Ocean State Crohn's and Colitis Area Registry. , 2009, Medicine and health, Rhode Island.

[33]  J. Doré,et al.  Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients , 2008, Proceedings of the National Academy of Sciences.

[34]  P. Munkholm,et al.  Changes in Clinical Characteristics, Course, and Prognosis of Inflammatory Bowel Disease during the Last 5 Decades: A Population‐Based Study from Copenhagen, Denmark , 2007, Inflammatory bowel diseases.

[35]  Daniel P. Faith,et al.  The Role of the Phylogenetic Diversity Measure, PD, in Bio-informatics: Getting the Definition Right , 2006, Evolutionary bioinformatics online.

[36]  R. Knight,et al.  UniFrac: a New Phylogenetic Method for Comparing Microbial Communities , 2005, Applied and Environmental Microbiology.

[37]  J. Satsangi,et al.  Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: report of a Working Party of the 2005 Montreal World Congress of Gastroenterology. , 2005, Canadian journal of gastroenterology = Journal canadien de gastroenterologie.

[38]  Keiichiro Suzuki,et al.  Aberrant expansion of segmented filamentous bacteria in IgA-deficient gut , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[39]  Marti J. Anderson,et al.  A new method for non-parametric multivariate analysis of variance in ecology , 2001 .

[40]  R. Modigliani,et al.  Clinical, biological, and endoscopic picture of attacks of Crohn's disease. Evolution on prednisolone. Groupe d'Etude Thérapeutique des Affections Inflammatoires Digestives. , 1990, Gastroenterology.

[41]  D. Iliopoulos,et al.  Environmental triggers in IBD: a review of progress and evidence , 2018, Nature Reviews Gastroenterology & Hepatology.